These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 11498184)

  • 1. Crossmatch in renal transplantation using a sensitive antiglobulin microlymphocytotoxicity test.
    Ayed K; Sassi F; Ben Abdallah T
    Transplant Proc; 2001 Aug; 33(5):2848-9. PubMed ID: 11498184
    [No Abstract]   [Full Text] [Related]  

  • 2. Simultaneous detection of antibody binding and cytotoxicity in flow cytometry crossmatch for renal transplantation.
    Won DI; Jeong HD; Kim YL; Suh JS
    Cytometry B Clin Cytom; 2006 Mar; 70(2):82-90. PubMed ID: 16470535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Two techniques to make the lymphocytotoxic crossmatch more sensitive: prolonged incubation and the antiglobulin test.
    Ross J; Dickerson T; Perkins HA
    Tissue Antigens; 1975 Sep; 6(3):129-36. PubMed ID: 1181663
    [TBL] [Abstract][Full Text] [Related]  

  • 4. General insufficiency of the classical CDC-based crossmatch to detect donor-specific anti-HLA antibodies leading to invalid results under recipients' medical treatment or underlying diseases.
    Schlaf G; Mauz-Körholz C; Ott U; Leike S; Altermann W
    Histol Histopathol; 2012 Jan; 27(1):31-8. PubMed ID: 22127594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interview with Dr Paul Terasaki.
    Terasaki P
    Am J Transplant; 2003 Sep; 3(9):1047-51. PubMed ID: 12919082
    [No Abstract]   [Full Text] [Related]  

  • 6. Positive antiglobulin cytotoxicity crossmatch in renal allograft recipients treated with cyclosporine.
    Gifford RR; Doran MM; Ruth JA; Coppage ML; Winsett OE; Fish JC
    Transplantation; 1986 Oct; 42(4):439-41. PubMed ID: 3532456
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical cytometry and progress in HLA antibody detection.
    Bray RA; Tarsitani C; Gebel HM; Lee JH
    Methods Cell Biol; 2011; 103():285-310. PubMed ID: 21722808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extra reactivities detected in flow-cytometry-positive, CDC-negative crossmatches are definable HLA specificities.
    Rodey G; Bollig B; Oldfather J; Schutte L; Flye W; Phelan D
    Transplant Proc; 1987 Feb; 19(1 Pt 1):778-9. PubMed ID: 3274872
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Panel-reactive antibodies using complement-dependent cytotoxicity, flow cytometry, and ELISA in patients awaiting renal transplantation or transplanted patients: a comparative study.
    Mansour I; Messaed C; Azoury M; Klayme S; Naaman R
    Transplant Proc; 2001 Aug; 33(5):2844-7. PubMed ID: 11498183
    [No Abstract]   [Full Text] [Related]  

  • 10. Renal transplantation in sensitized recipients with positive luminex and negative CDC (complement-dependent cytotoxicity) crossmatches.
    Huh KH; Kim MS; Kim HJ; Joo DJ; Kim BS; Ju MK; Kim SI; Kim YS
    Transpl Int; 2012 Nov; 25(11):1131-7. PubMed ID: 22897830
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The lymphocytotoxic crossmatch test in clinical renal transplantation.
    Ting A
    Transplantation; 1983 May; 35(5):403-7. PubMed ID: 6342217
    [No Abstract]   [Full Text] [Related]  

  • 12. Improved flow cytometry based cytotoxicity and binding assay for clinical antibody HLA crossmatching.
    Alheim M; Paul PK; Hauzenberger DM; Wikström AC
    Hum Immunol; 2015 Nov; 76(11):849-57. PubMed ID: 26429307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of crossmatching on outcome in organ transplantation.
    Wang-Rodriguez J; Rearden A
    Crit Rev Clin Lab Sci; 1995; 32(4):345-76. PubMed ID: 7576157
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complement-dependent lymphocytotoxicity crossmatch in deceased donor renal transplant: a single institutional experience.
    Deepa R; Balapriya P; Venkatesh KG; Sabeetha T; Sasikala J; Jayalakshmi G
    Indian J Med Microbiol; 2011; 29(4):414-7. PubMed ID: 22120805
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Variations of the lymphocytotoxicity test. An evaluation of sensitivity and specificity.
    Zachary AA; Klingman L; Thorne N; Smerglia AR; Teresi GA
    Transplantation; 1995 Sep; 60(5):498-503. PubMed ID: 7676500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Luminex-based virtual crossmatching for renal transplantation in South Africa.
    Worsley CM; Mayne ES; Suchard MS
    S Afr Med J; 2011 Dec; 102(1):40-3. PubMed ID: 22273137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Crossmatch testing in renal transplantation: comparative evaluation between an innovatory ELISA technique and two different standardised CDC methods.
    Nanni-Costa A; Scolari MP; Iannelli S; Buscaroli A; De Sanctis LB; Liviano D'Arcangelo G; Borgnino LC; Buttazzi R; Stefoni S; Bonomini V
    Transplant Proc; 1997; 29(1-2):1449-50. PubMed ID: 9123376
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparative study between cytotoxicity and flowcytometry crossmatches before and after renal transplantation.
    Abdel Rahman AS; Fahim NM; El Sayed AA; El Hady SA; Ahmad YS
    Egypt J Immunol; 2005; 12(2):77-89. PubMed ID: 17977213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Microlymphocytotoxicity test with anti-IgG antiglobulin and cross reactivity of HL-A antigens].
    Delmas-Marsalet Y; Woodbury M; Corley R; Amos DB
    Nouv Rev Fr Hematol; 1974; 14(3):409-16. PubMed ID: 4277879
    [No Abstract]   [Full Text] [Related]  

  • 20. Value of donor-specific antibody detection in first-graft renal transplant recipients with a negative complement-dependent cytotoxic crossmatch.
    Mahmoud KM; Ismail AM; Sheashaa HA; Gheith OA; Kamal MM; Ghoneim MA
    Exp Clin Transplant; 2009 Jun; 7(2):124-8. PubMed ID: 19715518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.